CDY
Click for more information
1.43% 7.1¢ cellmid limited

If Midkine has so much potential why can’t Cellmid make a media...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. maldowl
    3,154 Posts.
    lightbulb Created with Sketch. 47
    clock Created with Sketch.
    29/08/18
    18:45
    Post #: 35274083
    If Midkine has so much potential why can’t Cellmid make a media release like all the other cancer detecting biomarker products and companies are doing lately?
    The lack of progress with Midkine has been and always will be the downfall of the CEO and the company.
    Neither can deliver what new and present shareholders want.
    CDY Price at posting: 37.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Updated resource estimates soar for the Pepper Gold Deposit in Western Australia
right-arrow Created with Sketch.
USQ Expanded deep drilling gold program unveiled for Leonora flagship project
right-arrow Created with Sketch.
NEWS $6.2 million Government Grant secured by Hazer to progress technology commercialisation
right-arrow Created with Sketch.
NEWS Thrilling study results take Orthocell a step closer to FDA clearance
right-arrow Created with Sketch.
RMS Flicka Lake Project enters promising new era as highly encouraging results found
right-arrow Created with Sketch.
NEWS Peppermint looks to elevate AI and data transformation
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.